0

Fighting Triple Negative Female Breast Cancer by Blocking Androgen (Male) Receptors

Fighting Triple Negative Female Breast Cancer by Blocking Androgen (Male) Receptors
It may seem counter-intuitive,  a potentially powerful treatment for breast cancer based on blocking receptors for the male hormone androgen; but that’s what turns out to be the case. Researchers at the University of Colorado Cancer Center recently completed a Phase I clinical trial of Enzalutamide, which provided evidence of the safety and possible effectiveness of the approach.

Post a Comment

Note: Only a member of this blog may post a comment.

 
Top